Ophthalmic disease

Mouse studies suggest inhibiting CACNA2D1 could help treat ocular hypertension. In a mouse model of ocular hypertension, Lyrica pregabalin, which inhibits CACNAD21, decreased intraocular pressure compared with no treatment. Next steps could include identifying and testing specific CACNA2D1 inhibitors in models of ocular hypertension...